Share
USER HOTLINE: call us at +49 30 65499 145 | Not all products are available in the USA.
Expanding the dimension of blood purification Working to save lives together.
DGTHG 2025

Lunch Symposium: Hemoadsorption as safety net in cardiac surgery | 15. February, 13:45-14:45, Hamburg

Details
Webinar (in German)

Besonderheiten extrakorporaler Verfahren | February 26 | 15:00-16:00 CET | online

Programm and registration
New Blog Post

Prof. Daniel Wendt on the results of the second interim STAR Registry analysis

Read more
CytoSorbents & Hemoadsorption

When it comes to critical health challenges, count on us.

We understand that healthcare professionals need to be able to rely on technology that protects patients.

 

CytoSorbents’ powerful adsorption technology is expanding the dimensions of blood purification, with one of the fastest ways to restore balance and control damage – beyond what dialysis can do.

Our Innovation

The incomparable power of bead technology

Our solutions are based on our proprietary biocompatible, highly porous polymer bead technology, which works to effectively, safely, and selectively remove excessive levels of potentially harmful substances.

Our Team of Experts

Expertise you can count on the moment you need it.

Our Support

CytoSorbents in over 75 countries worldwide.

CytoSorbents

Voices around the world

world map
Critical Care
Dr. Christopher Rugg
Austria, Innsbruck

Catecholamines decreased within 24 h after initiation of CytoSorb Therapy; in-hospital mortality was significantly lower in the CytoSorb group (35.7% vs 61.9%).

Liver
Prof. Dana Tomescu
Romania, Bucharest

The use of CytoSorb in patients with severe acute pancreatitis was associated with improved hemodynamics and decreased inflammatory markers.

Critical Care
Prof. JW Awori Hayanga
USA, Morgantown

In COVID-19 ARDS on VV-ECMO + hemoadsorption, 90-day survival 74% and early intervention associated with shorter organ support, supporting “enhanced lung rest”.